198 related articles for article (PubMed ID: 37658805)
1. Identifying Mediators of Intervention Effects Within a Randomized Controlled Trial to Motivate Cancer Genetic Risk Assessment Among Breast and Ovarian Cancer Survivors.
An J; Lu SE; McDougall J; Walters ST; Lin Y; Heidt E; Stroup A; Paddock L; Grumet S; Toppmeyer D; Kinney AY
Ann Behav Med; 2023 Oct; 57(11):965-977. PubMed ID: 37658805
[TBL] [Abstract][Full Text] [Related]
2. Understanding cancer genetic risk assessment motivations in a remote tailored risk communication and navigation intervention randomized controlled trial.
Le Compte CG; Lu SE; Ani J; McDougall J; Walters ST; Toppmeyer D; Boyce TW; Stroup A; Paddock L; Grumet S; Lin Y; Heidt E; Kinney AY
Health Psychol Behav Med; 2022; 10(1):1190-1215. PubMed ID: 36518606
[TBL] [Abstract][Full Text] [Related]
3. Improving Uptake of Cancer Genetic Risk Assessment in a Remote Tailored Risk Communication and Navigation Intervention: Large Effect Size but Room to Grow.
Kinney AY; Walters ST; Lin Y; Lu SE; Kim A; Ani J; Heidt E; Le Compte CJG; O'Malley D; Stroup A; Paddock LE; Grumet S; Boyce TW; Toppmeyer DL; McDougall JA
J Clin Oncol; 2023 May; 41(15):2767-2778. PubMed ID: 36787512
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial promoting cancer genetic risk assessment when genetic counseling cost removed: 1-year follow-up.
An J; McDougall J; Lin Y; Lu SE; Walters ST; Heidt E; Stroup A; Paddock L; Grumet S; Toppmeyer D; Kinney AY
JNCI Cancer Spectr; 2024 Feb; 8(2):. PubMed ID: 38490263
[TBL] [Abstract][Full Text] [Related]
5. Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.
Kinney AY; Howell R; Ruckman R; McDougall JA; Boyce TW; Vicuña B; Lee JH; Guest DD; Rycroft R; Valverde PA; Gallegos KM; Meisner A; Wiggins CL; Stroup A; Paddock LE; Walters ST
Contemp Clin Trials; 2018 Oct; 73():123-135. PubMed ID: 30236776
[TBL] [Abstract][Full Text] [Related]
6. Development and pilot testing of a training for bilingual community education professionals about hereditary breast and ovarian cancer among Latinas: ÁRBOLES Familiares.
Vadaparampil ST; Moreno Botero L; Fuzzell L; Garcia J; Jandorf L; Hurtado-de-Mendoza A; Campos-Galvan C; Peshkin BN; Schwartz MD; Lopez K; Ricker C; Fiallos K; Quinn GP; Graves KD
Transl Behav Med; 2022 Jan; 12(1):. PubMed ID: 34255089
[TBL] [Abstract][Full Text] [Related]
7. Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.
Kukafka R; Pan S; Silverman T; Zhang T; Chung WK; Terry MB; Fleck E; Younge RG; Trivedi MS; McGuinness JE; He T; Dimond J; Crew KD
JAMA Netw Open; 2022 Jul; 5(7):e2222092. PubMed ID: 35849397
[TBL] [Abstract][Full Text] [Related]
8. Cultural adaptations to a telephone genetic counseling protocol and booklet for Latina breast cancer survivors at risk for hereditary breast and ovarian cancer.
Gómez-Trillos S; Graves KD; Fiallos K; Schwartz MD; Peshkin BN; Hamilton H; Sheppard VB; Vadaparampil ST; Campos C; Cupertino AP; Alzamora MC; Lynce F; Hurtado-de-Mendoza A
Transl Behav Med; 2023 May; 13(5):297-308. PubMed ID: 36694918
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled intervention to promote readiness to genetic counseling for breast cancer survivors.
Kasting ML; Conley CC; Hoogland AI; Scherr CL; Kim J; Thapa R; Reblin M; Meade CD; Lee MC; Pal T; Quinn GP; Vadaparampil ST
Psychooncology; 2019 May; 28(5):980-988. PubMed ID: 30883986
[TBL] [Abstract][Full Text] [Related]
10. Insights into BRCA1/2 Genetic Counseling from Ethnically Diverse Latina Breast Cancer Survivors.
Rajpal N; Muñoz J; Peshkin BN; Graves KD
J Genet Couns; 2017 Dec; 26(6):1221-1237. PubMed ID: 28374142
[TBL] [Abstract][Full Text] [Related]
11. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
[TBL] [Abstract][Full Text] [Related]
12. A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.
Hoskins KF; Tejeda S; Vijayasiri G; Chukwudozie IB; Remo MH; Shah HA; Abraham IE; Balay LE; Maga TK; Searles ER; Korah VJ; Biggers A; Stolley MR; Warnecke RB
Cancer; 2018 Sep; 124(18):3733-3741. PubMed ID: 30320429
[TBL] [Abstract][Full Text] [Related]
13. A pilot randomized trial of an educational intervention to increase genetic counseling and genetic testing among Latina breast cancer survivors.
Conley CC; Castro-Figueroa EM; Moreno L; Dutil J; García JD; Burgos C; Ricker C; Kim J; Graves KD; Ashing KT; Quinn GP; Soliman H; Vadaparampil ST
J Genet Couns; 2021 Apr; 30(2):394-405. PubMed ID: 32936981
[TBL] [Abstract][Full Text] [Related]
14. Genetic Testing in a Population-Based Sample of Breast and Ovarian Cancer Survivors from the REACH Randomized Trial: Cost Barriers and Moderators of Counseling Mode.
Steffen LE; Du R; Gammon A; Mandelblatt JS; Kohlmann WK; Lee JH; Buys SS; Stroup AM; Campo RA; Flores KG; Vicuña B; Schwartz MD; Kinney AY
Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1772-1780. PubMed ID: 28971986
[No Abstract] [Full Text] [Related]
15. Addressing disparities in the uptake of genetic counseling and testing in African American women; rationale, design and methods.
Sheppard VB; Sutton AL; Hurtado-De-Mendoza A; Tariq F; Perera RA; Quillin J; Jeudy M; Gómez-Trillos S; Schwartz MD
Contemp Clin Trials; 2023 Jul; 130():107210. PubMed ID: 37142159
[TBL] [Abstract][Full Text] [Related]
16. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
[TBL] [Abstract][Full Text] [Related]
17. Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
Arun BK; Peterson SK; Sweeney LE; Bluebond RD; Tidwell RSS; Makhnoon S; Kushwaha AC
Cancer; 2022 Jan; 128(1):94-102. PubMed ID: 34424535
[TBL] [Abstract][Full Text] [Related]
18. Use of a Standardized Tool to Identify Women at Risk for Hereditary Breast and Ovarian.
Hessock M; Brewer T; Hutson S; Anderson J
Nurs Womens Health; 2021 Jun; 25(3):187-197. PubMed ID: 33933425
[TBL] [Abstract][Full Text] [Related]
19. Provider discussion of genetic counseling among high-risk Spanish-preferring Latina breast cancer survivors.
Conley CC; Rivera Rivera JN; Castro-Figueroa EM; Moreno L; Dutil J; García JD; Ricker C; Quinn GP; Soliman H; Vadaparampil ST
Transl Behav Med; 2022 Oct; 12(9):900-908. PubMed ID: 36205471
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
